Human Placental-Derived Stem Cell Transplantation
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
- Estimated Enrollment
- 30
Summary
- Conditions
- Batten Disease
- Acute Lymphocytic Leukemia
- Acute Myelogenous Leukemia
- Adrenoleukodystrophy
- Amegakaryocytic Thrombocytopenia
- Niemann-Pick Disease
- Diamond Blackfan Anemia
- Fucosidosis
- Severe Aplastic Anemia
- Myelodysplastic Syndrome
- Gaucher's Disease
- Mucopolysaccharidosis VI
- Wolman Disease
- Krabbe's Disease
- Metachromatic Leukodystrophy
- Mucopolysaccharidosis I
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: Non-RandomizedIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Younger than 55 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT01586455
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Mitchell S Cairo, MD New York Medical College